Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Rayson

Showing results (51-60 of 86) with videos related to

Pageof 9
Sort By:
Breast (Edinburgh, Scotland)|July 28, 2009
Survivin and COX-2 expression in male breast carcinomaTallal Younis, Kelly Dakin Haché, Daniel Rayson, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 2, 2008
Waiting times in early-stage non-small cell lung cancer (NSCLC)Nathalie Saint-Jacques, Daniel Rayson, Turki Al-Fayea, et al.
Annals of Diagnostic Pathology|April 29, 2022
HER2 testing in metastatic breast cancer - Is reflex ISH testing necessary on HER2 IHC-equivocal (2+) cases?Christopher R Liwski, Mathieu C Castonguay, Penny J Barnes, et al.
Clinical Breast Cancer|December 14, 2011
Routine cardiac evaluation in patients with early-stage breast cancer before adjuvant chemotherapyAlwin Jeyakumar, Jillian DiPenta, Stephanie Snow, et al.
The Oncologist|November 20, 2016
Enhancing Endocrine Therapy Combination Strategies for the Treatment of Postmenopausal HR+/HER2- Advanced Breast CancerKathleen I Pritchard, Stephen K Chia, Christine Simmons, et al.
Clinical Breast Cancer|June 11, 2018
Impact of Detection Method and Age on Survival Outcomes in Triple-Negative Breast Cancer: A Population-Based Cohort AnalysisDaniel Rayson, Jennifer I Payne, James C R Michael, et al.
Implementation Science : IS|October 27, 2012
How do surgeons decide to refer patients for adjuvant cancer treatment? Protocol for a qualitative studyRobin Urquhart, Cynthia Kendell, Joan Sargeant, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 11, 2020
ASCO Voices 2020Daniel Rayson, Jose A Bufill, Julia Close, et al.
CMAJ Open|August 30, 2016
Decision-making by surgeons about referral for adjuvant therapy for patients with non-small-cell lung, breast or colorectal cancer: a qualitative studyRobin Urquhart, Cynthia Kendell, Gordon Buduhan, et al.
Archives of Pathology & Laboratory Medicine|December 2, 2011
Loss of expression of DNA mismatch repair proteins is rare in pancreatic and small intestinal neuroendocrine tumorsThomas Arnason, Heidi L Sapp, Daniel Rayson, et al.
Pageof 9

Showing results (51-60 of 86) with videos related to

Sort By:
Pageof 9
Breast (Edinburgh, Scotland)|July 28, 2009
Survivin and COX-2 expression in male breast carcinomaTallal Younis, Kelly Dakin Haché, Daniel Rayson, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 2, 2008
Waiting times in early-stage non-small cell lung cancer (NSCLC)Nathalie Saint-Jacques, Daniel Rayson, Turki Al-Fayea, et al.
Annals of Diagnostic Pathology|April 29, 2022
HER2 testing in metastatic breast cancer - Is reflex ISH testing necessary on HER2 IHC-equivocal (2+) cases?Christopher R Liwski, Mathieu C Castonguay, Penny J Barnes, et al.
Clinical Breast Cancer|December 14, 2011
Routine cardiac evaluation in patients with early-stage breast cancer before adjuvant chemotherapyAlwin Jeyakumar, Jillian DiPenta, Stephanie Snow, et al.
The Oncologist|November 20, 2016
Enhancing Endocrine Therapy Combination Strategies for the Treatment of Postmenopausal HR+/HER2- Advanced Breast CancerKathleen I Pritchard, Stephen K Chia, Christine Simmons, et al.
Clinical Breast Cancer|June 11, 2018
Impact of Detection Method and Age on Survival Outcomes in Triple-Negative Breast Cancer: A Population-Based Cohort AnalysisDaniel Rayson, Jennifer I Payne, James C R Michael, et al.
Implementation Science : IS|October 27, 2012
How do surgeons decide to refer patients for adjuvant cancer treatment? Protocol for a qualitative studyRobin Urquhart, Cynthia Kendell, Joan Sargeant, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 11, 2020
ASCO Voices 2020Daniel Rayson, Jose A Bufill, Julia Close, et al.
CMAJ Open|August 30, 2016
Decision-making by surgeons about referral for adjuvant therapy for patients with non-small-cell lung, breast or colorectal cancer: a qualitative studyRobin Urquhart, Cynthia Kendell, Gordon Buduhan, et al.
Archives of Pathology & Laboratory Medicine|December 2, 2011
Loss of expression of DNA mismatch repair proteins is rare in pancreatic and small intestinal neuroendocrine tumorsThomas Arnason, Heidi L Sapp, Daniel Rayson, et al.
Pageof 9